Dianthus Therapeutics (DNTH) Metrics: History & Chart

Dianthus Therapeutics, Inc.(DNTH)

Biotechnology · New York, NY

$84.49-3.55 (-4.03%)

Delayed quote: Oct 6, 2026, 10:40 AM EDT

About Dianthus Therapeutics, Inc.

Dianthus Therapeutics, Inc., a clinical-stage biotechnology company, engages in the development of therapies for patients with severe autoimmune diseases. Its lead clinical-stage candidate, claseprubart, a monoclonal antibody engineered with extended half-life, improved potency, and high selectivity for only the active C1s complement protein; and DNTH212, a bifunctional fusion protein that targets plasmacytoid dendritic cell (pDC) BDCA2 to reduce Type 1 interferon production, while simultaneously inhibiting BAFF/APRIL to suppress B cell function. Dianthus Therapeutics, Inc. was founded in 2019 and is headquartered in New York, New York.

New York, NY

92 employees

dianthustx.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Marino Garcia

View full financials

Third-Party DCF Estimate (FMP)	N/A
Price Gap vs Third-Party Estimate	N/A

7D Total Return	+0.24%
30D Total Return	-18.56%
YTD Total Return	+113.64%
1Y Total Return	+151.97%
3Y Total Return	+633.65%
5Y Total Return	-24.63%
10Y Total Return	N/A
15Y Total Return	N/A
20Y Total Return	N/A

2026	+113.64%
2025	+89.04%
2024	+109.62%
2023	+64.56%
2022	-91.08%
2021	-43.49%
2020

CAGR TTM	+150.87%
CAGR 3Y	+94.28%
CAGR 5Y	-5.50%
CAGR 10Y	N/A
CAGR 15Y	N/A
CAGR 20Y	N/A

PE Ratio	N/A
PE Ratio Avg TTM	N/A
PE Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

All Metrics

DNTH Valuation Metrics

DNTH Stock Price Metrics

DNTH Dividend Metrics

DNTH Growth Rate Metrics

DNTH Discounted Cash Flow Metrics

DNTH Returns By Period

DNTH Yearly Returns

DNTH Average Annual Returns By Period (CAGR)

DNTH Revenue Metrics

DNTH PE Ratio Metrics

DNTH PS Ratio Metrics

DNTH PB Ratio Metrics

DNTH Price to Free Cash Flow Ratio Metrics

DNTH Debt to Equity Ratio Metrics

DNTH PEG Ratio Metrics

DNTH FCF Yield

DNTH Earnings Yield

DNTH EBITDA Yield

DNTH OCF Yield

DNTH EV/EBIT Ratio Metrics

DNTH EV/EBITDA Ratio Metrics

DNTH EV/Assets Ratio Metrics

DNTH EV/Sales Ratio Metrics

DNTH Current Ratio Metrics

DNTH Quick Ratio Metrics

DNTH ROIC Metrics

DNTH Return on Assets Metrics

DNTH Return on Equity Metrics

DNTH Net Profit Margin Metrics

DNTH Gross Profit Margin Metrics

DNTH Tax Rate Metrics

PS Ratio	2590.76
PS Ratio Avg TTM	1806.21
PS Ratio Avg 3Y	190.69
Current VS TTM Avg	+43.44%
Current VS 3Y Avg	+1258.63%
Current VS 5Y Avg	+1856.46%

PB Ratio	4.21
PB Ratio Avg TTM	4.23
PB Ratio Avg 3Y	2.38
Current VS TTM Avg	-0.56%
Current VS 3Y Avg	+76.56%
Current VS 5Y Avg	+136.34%

PFCF Ratio	N/A
PFCF Ratio Avg TTM	N/A
PFCF Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Debt/Equity Ratio	0.00
Debt/Equity Ratio Avg TTM	0.00
Debt/Equity Ratio Avg 3Y	0.00
Current VS TTM Avg	-53.40%
Current VS 3Y Avg	-53.76%
Current VS 5Y Avg	-39.53%

PEG Ratio	N/A
PEG Ratio Avg TTM	N/A
PEG Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

FCF Yield	N/A
FCF Yield Avg TTM	N/A
FCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Earnings Yield	N/A
Earnings Yield Avg TTM	N/A
Earnings Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

EBITDA Yield	N/A
EBITDA Yield Avg TTM	N/A
EBITDA Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

OCF Yield	N/A
OCF Yield Avg TTM	N/A
OCF Yield Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebit Ratio	N/A
Ev/Ebit Ratio Avg TTM	N/A
Ev/Ebit Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Ebitda Ratio	N/A
Ev/Ebitda Ratio Avg TTM	N/A
Ev/Ebitda Ratio Avg 3Y	N/A
Current VS TTM Avg	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A

Ev/Assets Ratio	3.98
Ev/Assets Ratio Avg TTM	3.83
Ev/Assets Ratio Avg 3Y	2.50
Current VS TTM Avg	+4.03%
Current VS 3Y Avg	+59.05%
Current VS 5Y Avg	+127.74%

Ev/Sales Ratio	2533.37
Ev/Sales Ratio Avg TTM	1670.59
Ev/Sales Ratio Avg 3Y	221.19
Current VS TTM Avg	+51.65%
Current VS 3Y Avg	+1045.34%
Current VS 5Y Avg	+1301.63%

Current Ratio	26.10
Current Ratio Avg TTM	19.83
Current Ratio Avg 3Y	19.81
Current VS TTM Avg	+31.63%
Current VS 3Y Avg	+31.78%
Current VS 5Y Avg	+64.81%

Quick Ratio	26.10
Quick Ratio Avg TTM	19.83
Quick Ratio Avg 3Y	19.79
Current VS TTM Avg	+31.63%
Current VS 3Y Avg	+31.90%
Current VS 5Y Avg	+64.81%

ROIC	(18.48%)
ROIC Avg 3Y	(28.18%)
ROIC Avg 5Y	(33.77%)
Current VS 3Y Avg	+34.43%
Current VS 5Y Avg	+45.29%
Current VS 10Y Avg	+54.64%

ROA	(2.47%)
ROA Avg TTM	(1.01%)
ROA Avg 3Y	(6.23%)
Current VS TTM Avg	-145.05%
Current VS 3Y Avg	+60.38%
Current VS 5Y Avg	+68.36%

ROE	(2.55%)
ROE Avg TTM	(12.90%)
ROE Avg 3Y	(18.20%)
Current VS TTM Avg	+80.23%
Current VS 3Y Avg	+85.99%
Current VS 5Y Avg	+92.06%

Net Profit Margin	(1570.85%)
Net Profit Margin Avg TTM	(1323.32%)
Net Profit Margin Avg 3Y	(3465.47%)
Current VS TTM Avg	-18.71%
Current VS 3Y Avg	+54.67%
Current VS 5Y Avg	-52.96%

Gross Profit Margin	96.01%
Gross Pft Margin Avg TTM	96.72%
Gross Pft Margin Avg 3Y	100.00%
Current VS TTM Avg	-0.73%
Current VS 3Y Avg	-3.99%
Current VS 5Y Avg	-2.07%

Tax Rate	0.00%
Tax Rate Avg 3Y	N/A
Tax Rate Avg 5Y	N/A
Current VS 3Y Avg	N/A
Current VS 5Y Avg	N/A
Current VS 10Y Avg	N/A